Shopping Cart 0
Cart Subtotal
USD 0

Eurofins Scientific SE (ERF) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375

Details

Eurofins Scientific SE (ERF)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Eurofins Scientific SE (Eurofins) is a life sciences company, which provides a range of analytical testing services. The company offers food and feed testing, biopharma services, pharma discovery services, genomic pharma services, pharma early development, pharma central laboratory, biopharma product testing, genomic services, agro-science services, product testing, forensic services, environmental testing and Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) services. Its analytical methods help in evaluating the safety, identity, composition, origin, authenticity and purity of biological products and substances. It harnesses its expertise in logistics and information technology to deliver a range of services. The company operates across Europe, North and South America, and Asia-Pacific. Eurofins is headquartered in Luxembourg.

Eurofins Scientific SE Key Recent Developments

Apr 26,2019: Eurofins revenues grow 27% in Q1 2019 to EUR 1,067m

Mar 05,2019: Eurofins delivers solid FY 2018 results with revenues of EUR 3,781m and adjusted EBITDA of EUR 720m (19.0% of revenues), in line with its recently upgraded objectives

Nov 20,2018: Eurofins to distribute Synthego's industry-best genome engineering products in global channels

Oct 23,2018: Eurofins posts strong revenue growth in Q3 2018 (EUR 955m, +30.6% yoy including over 5% organic growth) and raises its objectives for 2019-2020-Revenues objective for 2020 now set at EUR 5bn

Oct 02,2018: Eurofins BioPharma Product Testing Ireland opened the new extension in Dungarvan

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Eurofins Scientific SE-Key Facts

Eurofins Scientific SE-Key Employees

Eurofins Scientific SE-Key Employee Biographies

Eurofins Scientific SE-Major Products and Services

Eurofins Scientific SE-History

Eurofins Scientific SE-Company Statement

Eurofins Scientific SE-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Eurofins Scientific SE-Business Description

Product Category: Agroscience Services

Overview

Product Category: Biopharma Services

Overview

Product Category: Clinical Diagnostics

Overview

Product Category: Consumer Product Testing

Overview

Product Category: Environmental Testing

Overview

Product Category: Food and Feed Testing

Overview

Product Category: Genomics Services

Overview

Product Category: REACH Services

Overview

Geographical Segment: Benelux

Performance

Geographical Segment: France

Performance

Geographical Segment: Germany

Performance

Geographical Segment: Nordic Region

Performance

Geographical Segment: North America

Performance

Geographical Segment: Rest of the World

Performance

Geographical Segment: Total Western Europe

Performance

Geographical Segment: UK & Ireland

Performance

Eurofins Scientific SE-SWOT Analysis

SWOT Analysis-Overview

Eurofins Scientific SE-Strengths

Eurofins Scientific SE-Weaknesses

Eurofins Scientific SE-Opportunities

Eurofins Scientific SE-Threats

Eurofins Scientific SE-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences, Power Financial Deals and Alliances

Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Eurofins Scientific SE, Recent Deals Summary

Section 5-Company's Recent Developments

Apr 26, 2019: Eurofins revenues grow 27% in Q1 2019 to EUR 1,067m

Mar 05, 2019: Eurofins delivers solid FY 2018 results with revenues of EUR 3,781m and adjusted EBITDA of EUR 720m (19.0% of revenues), in line with its recently upgraded objectives

Nov 20, 2018: Eurofins to distribute Synthego's industry-best genome engineering products in global channels

Oct 23, 2018: Eurofins posts strong revenue growth in Q3 2018 (EUR 955m, +30.6% yoy including over 5% organic growth) and raises its objectives for 2019-2020-Revenues objective for 2020 now set at EUR 5bn

Oct 02, 2018: Eurofins BioPharma Product Testing Ireland opened the new extension in Dungarvan

Jul 31, 2018: Eurofins delivers strong revenue, profitability and cash flow growth in H1 2018

Jun 26, 2018: Eurofins raises its revenues objectives for 2018 to EUR 3.8bn (4bn pro-forma), to 4.3bn for 2019 and to 4.7bn for 2020

May 22, 2018: Eurofins expands its biopharmaceutical products testing footprint with an outsourcing agreement with Astellas in Japan

Apr 24, 2018: Eurofins revenues grow +23% in Q1 2018 to EUR 839m

Mar 06, 2018: Eurofins exceeds its recently-upgraded 2017 objectives on a strong growth momentum and raises its objectives for 2018

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Eurofins Scientific SE, Performance Chart (2014-2018)

Eurofins Scientific SE, Ratio Charts

Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Eurofins Scientific SE, Key Facts

Eurofins Scientific SE, Key Employees

Eurofins Scientific SE, Key Employee Biographies

Eurofins Scientific SE, Major Products and Services

Eurofins Scientific SE, History

Eurofins Scientific SE, Subsidiaries

Eurofins Scientific SE, Key Competitors

Eurofins Scientific SE, Ratios based on current share price

Eurofins Scientific SE, Annual Ratios

Eurofins Scientific SE, Annual Ratios (Cont...1)

Eurofins Scientific SE, Annual Ratios (Cont...2)

Eurofins Scientific SE, Interim Ratios

Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Eurofins Scientific SE, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Eurofins Scientific SE, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

SGS SA

R-Biopharm AG

Intertek Group Plc

Bureau Veritas SA

bioMerieux SA

Company Profile

Company Profile Title

Eurofins Scientific SE (ERF)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Eurofins Scientific SE (Eurofins) is a life sciences company, which provides a range of analytical testing services. The company offers food and feed testing, biopharma services, pharma discovery services, genomic pharma services, pharma early development, pharma central laboratory, biopharma product testing, genomic services, agro-science services, product testing, forensic services, environmental testing and Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) services. Its analytical methods help in evaluating the safety, identity, composition, origin, authenticity and purity of biological products and substances. It harnesses its expertise in logistics and information technology to deliver a range of services. The company operates across Europe, North and South America, and Asia-Pacific. Eurofins is headquartered in Luxembourg.

Eurofins Scientific SE Key Recent Developments

Apr 26,2019: Eurofins revenues grow 27% in Q1 2019 to EUR 1,067m

Mar 05,2019: Eurofins delivers solid FY 2018 results with revenues of EUR 3,781m and adjusted EBITDA of EUR 720m (19.0% of revenues), in line with its recently upgraded objectives

Nov 20,2018: Eurofins to distribute Synthego's industry-best genome engineering products in global channels

Oct 23,2018: Eurofins posts strong revenue growth in Q3 2018 (EUR 955m, +30.6% yoy including over 5% organic growth) and raises its objectives for 2019-2020-Revenues objective for 2020 now set at EUR 5bn

Oct 02,2018: Eurofins BioPharma Product Testing Ireland opened the new extension in Dungarvan

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Eurofins Scientific SE-Key Facts

Eurofins Scientific SE-Key Employees

Eurofins Scientific SE-Key Employee Biographies

Eurofins Scientific SE-Major Products and Services

Eurofins Scientific SE-History

Eurofins Scientific SE-Company Statement

Eurofins Scientific SE-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Eurofins Scientific SE-Business Description

Product Category: Agroscience Services

Overview

Product Category: Biopharma Services

Overview

Product Category: Clinical Diagnostics

Overview

Product Category: Consumer Product Testing

Overview

Product Category: Environmental Testing

Overview

Product Category: Food and Feed Testing

Overview

Product Category: Genomics Services

Overview

Product Category: REACH Services

Overview

Geographical Segment: Benelux

Performance

Geographical Segment: France

Performance

Geographical Segment: Germany

Performance

Geographical Segment: Nordic Region

Performance

Geographical Segment: North America

Performance

Geographical Segment: Rest of the World

Performance

Geographical Segment: Total Western Europe

Performance

Geographical Segment: UK & Ireland

Performance

Eurofins Scientific SE-SWOT Analysis

SWOT Analysis-Overview

Eurofins Scientific SE-Strengths

Eurofins Scientific SE-Weaknesses

Eurofins Scientific SE-Opportunities

Eurofins Scientific SE-Threats

Eurofins Scientific SE-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences, Power Financial Deals and Alliances

Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Eurofins Scientific SE, Recent Deals Summary

Section 5-Company's Recent Developments

Apr 26, 2019: Eurofins revenues grow 27% in Q1 2019 to EUR 1,067m

Mar 05, 2019: Eurofins delivers solid FY 2018 results with revenues of EUR 3,781m and adjusted EBITDA of EUR 720m (19.0% of revenues), in line with its recently upgraded objectives

Nov 20, 2018: Eurofins to distribute Synthego's industry-best genome engineering products in global channels

Oct 23, 2018: Eurofins posts strong revenue growth in Q3 2018 (EUR 955m, +30.6% yoy including over 5% organic growth) and raises its objectives for 2019-2020-Revenues objective for 2020 now set at EUR 5bn

Oct 02, 2018: Eurofins BioPharma Product Testing Ireland opened the new extension in Dungarvan

Jul 31, 2018: Eurofins delivers strong revenue, profitability and cash flow growth in H1 2018

Jun 26, 2018: Eurofins raises its revenues objectives for 2018 to EUR 3.8bn (4bn pro-forma), to 4.3bn for 2019 and to 4.7bn for 2020

May 22, 2018: Eurofins expands its biopharmaceutical products testing footprint with an outsourcing agreement with Astellas in Japan

Apr 24, 2018: Eurofins revenues grow +23% in Q1 2018 to EUR 839m

Mar 06, 2018: Eurofins exceeds its recently-upgraded 2017 objectives on a strong growth momentum and raises its objectives for 2018

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Eurofins Scientific SE, Performance Chart (2014-2018)

Eurofins Scientific SE, Ratio Charts

Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Eurofins Scientific SE, Key Facts

Eurofins Scientific SE, Key Employees

Eurofins Scientific SE, Key Employee Biographies

Eurofins Scientific SE, Major Products and Services

Eurofins Scientific SE, History

Eurofins Scientific SE, Subsidiaries

Eurofins Scientific SE, Key Competitors

Eurofins Scientific SE, Ratios based on current share price

Eurofins Scientific SE, Annual Ratios

Eurofins Scientific SE, Annual Ratios (Cont...1)

Eurofins Scientific SE, Annual Ratios (Cont...2)

Eurofins Scientific SE, Interim Ratios

Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Eurofins Scientific SE, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Eurofins Scientific SE, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

SGS SA

R-Biopharm AG

Intertek Group Plc

Bureau Veritas SA

bioMerieux SA